Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vinorelbine as second-line therapy for malignant pleural mesothelioma
2014-001992-30Phase 2Unknown
- Sponsor
- University of Leicester
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vinorelbine in pleural mesothelioma (2 arms), sponsored by University of Leicester. Primary endpoint: Overall survival. Status: unknown.
02
Drugs
vinorelbine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2014-001992-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001992-30.